(PR-inside.com) - Oxygen Biotherapeutics, Inc. (OTCBB:OXBO) today announced the appointment of Charles H. Seeman as the company's chief financial officer and executive vice president finance and administration. 'Charles is a regulatory and compliance expert and will be a great addition to our team,' said company chairman and CEO Chris J. Stern, DBA. 'He has a proven track record of extensive SEC reporting, financial statement preparation, and accounting management, all skills the company will need as we move forward with our multi-product strategy of therapeutic oxygen carriers.' Seeman is a CPA. In addition to prior experience as a CFO and ..
More...
More...